Over the next 18 years (1998–2016), the focus gradually shifted to intervention effect, tumor necrosis factor-alpha, clinical trial, encephalitis, reperfusion injury, sepsis, anti-inflammatory activity, mechanism of action, innate immunity, and astrocytes. This evidence concerns the gene TNF and viral encephalitis.